Sheila D. Banks

Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.

David S. Duch, Sheila D. Banks, I K Dev et al. · PubMed · 1993 · 114 citations

Life Sciences, Biochemistry, Pharmacology +9

Toward Antibody-directed Enzyme Prodrug Therapy with the T268G Mutant of Human Carboxypeptidase A1 and Novel in VivoStable Prodrugs of Methotrexate

Gary K. Smith, Sheila D. Banks, Todd A. Blumenkopf et al. · Journal of Biological Chemistry · 1997 · 66 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Activity of an NAD-dependent 5,10-methylenetetrahydrofolate dehydrogenase in normal tissue, neoplastic cells, and oncogene-transformed cells

Gary K. Smith, Sheila D. Banks, Thomas J. Monaco et al. · Archives of Biochemistry and Biophysics · 1990 · 30 citations

Life Sciences, Biochemistry, Molecular Biology +15

Destruction of WiDr multicellular tumor spheroids with the novel thymidylate synthase inhibitor 1843U89 at physiological thymidine concentrations

Sheila D. Banks, Kathleen A. Waters, Linda Barrett et al. · Cancer Chemotherapy and Pharmacology · 1994 · 16 citations

Medicine, Oncology, Pharmacology +6